Smith & Nephew (SNN) Capital Expenditures (2009 - 2024)

Smith & Nephew (SNN) posted quarterly Capital Expenditures of -$172.0 million for Q4 2024, down 2.99% year-on-year from -$177.3 million in Q1 2024, and down 2.99% on a QoQ basis from -$167.0 million in Q4 2023.

Smith & Nephew (SNN) Capital Expenditures (2009 - 2024) Analysis & Trends

Smith & Nephew (SNN) has reported Capital Expenditures for 16 consecutive years, with -$172.0 million the latest figure, recorded in Q4 2024.

  • Quarterly Capital Expenditures fell 2.99% year-over-year to -$172.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$687.0 million (up 2.28% YoY) and the FY2025 annual result came in at $433.0 million, up 13.65% from the prior year.
  • Capital Expenditures slipped to -$172.0 million in Q4 2024 per SNN's latest filing, from -$167.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for SNN reached as high as -$167.0 million in Q4 2023 and fell as low as -$188.0 million in Q4 2020.
  • A 5-year average of -$175.0 million and a median of -$173.0 million in 2022 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2020 — Capital Expenditures jumped 53.92% — and 2024, when it decreased 2.99%.
  • Year by year, Capital Expenditures stood at -$188.0 million in 2020, then climbed by 6.91% to -$175.0 million in 2021, then gained by 1.14% to -$173.0 million in 2022, then rose by 3.47% to -$167.0 million in 2023, then dropped by 2.99% to -$172.0 million in 2024.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$172.0 million, -$167.0 million, and -$173.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 399.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 166.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 488.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 64.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 76.60 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -85.46 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 178.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 90.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -172.00 Mn
Dec 31, 2024 -172.00 Mn
Dec 31, 2023 -167.00 Mn
Dec 31, 2023 -167.00 Mn
Dec 31, 2022 -173.00 Mn
Dec 31, 2022 -173.00 Mn
Dec 31, 2021 -175.00 Mn
Dec 31, 2021 -175.00 Mn
Dec 31, 2020 -188.00 Mn
Dec 31, 2020 -188.00 Mn
Dec 31, 2019 -408.00 Mn
Dec 31, 2019 -408.00 Mn
Dec 31, 2018 -347.00 Mn
Dec 31, 2018 -347.00 Mn
Dec 31, 2017 -376.00 Mn
Dec 31, 2017 -376.00 Mn
Dec 31, 2016 -392.00 Mn
Dec 31, 2016 -392.00 Mn
Dec 31, 2015 -358.00 Mn
Dec 31, 2015 -358.00 Mn